Published in J Biol Chem on June 21, 2002
Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine reduces of 1.5 log copies/mL the HIV RNA rebound median and no HIV DNA rebound following cART interruption in a phase I/II randomized controlled clinical trial. Retrovirology (2016) 1.42
What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology (2009) 1.15
Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol (2007) 1.07
Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. Retrovirology (2006) 0.90
Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant. Retrovirology (2008) 0.88
Impact of Tat Genetic Variation on HIV-1 Disease. Adv Virol (2012) 0.85
HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells. J Biol Chem (2009) 0.85
Sequence variation within the dominant amino terminus epitope affects antibody binding and neutralization of human immunodeficiency virus type 1 Tat protein. J Virol (2004) 0.82
Generation and characterization of neutralizing human monoclonal antibodies against human immunodeficiency virus type 1 Tat antigen. J Virol (2004) 0.81
Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virus. Vaccine (2014) 0.81
Identification of a highly conserved surface on Tat variants. J Biol Chem (2013) 0.80
A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade. J Biol Chem (2012) 0.80
Molecular characterization of full-length Tat in HIV-1 subtypes B and C. Bioinformation (2015) 0.78
A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes. Virol J (2017) 0.75
Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort. BMC Infect Dis (2016) 0.75
HIV-1 Tat Binding to PCAF Bromodomain: Structural Determinants from Computational Methods. Biology (Basel) (2012) 0.75
Acyl carrier protein/SpoT interaction, the switch linking SpoT-dependent stress response to fatty acid metabolism. Mol Microbiol (2006) 1.82
Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr (2007) 1.64
The bacterial two-hybrid system based on adenylate cyclase reconstitution in Escherichia coli. Methods (2012) 1.50
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus Abacavir. J Infect Dis (2010) 1.36
Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF. EMBO J (2002) 1.27
Antigen 84, an effector of pleiomorphism in Mycobacterium smegmatis. J Bacteriol (2007) 1.24
What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine? Retrovirology (2009) 1.15
The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis. J Biol Chem (2004) 1.13
Role of protein kinase G in growth and glutamine metabolism of Mycobacterium bovis BCG. J Bacteriol (2005) 1.08
Bacteria possessing two RelA/SpoT-like proteins have evolved a specific stringent response involving the acyl carrier protein-SpoT interaction. J Bacteriol (2008) 1.07
Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes. J Virol (2007) 1.07
HIV-1 Tat protein enhances microtubule polymerization. Retrovirology (2005) 1.06
The hotdog thioesterase EntH (YbdB) plays a role in vivo in optimal enterobactin biosynthesis by interacting with the ArCP domain of EntB. J Bacteriol (2007) 1.02
A protein network for phospholipid synthesis uncovered by a variant of the tandem affinity purification method in Escherichia coli. Proteomics (2006) 1.01
Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoring. J Acquir Immune Defic Syndr (2010) 1.01
Analysis of the Escherichia coli Tol-Pal and TonB systems by periplasmic production of Tol, TonB, colicin, or phage capsid soluble domains. Biochimie (2002) 0.99
Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol Biochem Behav (2006) 0.98
Differential expression of a virulence factor in pathogenic and non-pathogenic mycobacteria. Mol Microbiol (2009) 0.97
Injecting drug users in Bangladesh: prevalence of syphilis, hepatitis, HIV and HIV subtypes. AIDS (2002) 0.94
Antiretroviral therapy does not block the secretion of the human immunodeficiency virus tat protein. Infect Disord Drug Targets (2012) 0.92
Antagonistic regulation of dgkA and plsB genes of phospholipid synthesis by multiple stress responses in Escherichia coli. Mol Microbiol (2011) 0.92
The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells. J Biol Chem (2005) 0.92
Lithostathine quadruple-helical filaments form proteinase K-resistant deposits in Creutzfeldt-Jakob disease. J Biol Chem (2003) 0.91
Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine. Retrovirology (2006) 0.90
Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins. AIDS Res Hum Retroviruses (2010) 0.89
Identification of a Rhodobacter capsulatus L-cysteine desulfurase that sulfurates the molybdenum cofactor when bound to XdhC and before its insertion into xanthine dehydrogenase. Biochemistry (2007) 0.89
Transcription of the Escherichia coli fatty acid synthesis operon fabHDG is directly activated by FadR and inhibited by ppGpp. J Bacteriol (2013) 0.88
Oligomeric-induced activity by thienyl pyrimidine compounds traps prion infectivity. J Neurosci (2011) 0.88
Genotypic variation in the pol gene of HIV type 1 in an antiretroviral treatment-naive population in rural southwestern Uganda. AIDS Res Hum Retroviruses (2006) 0.88
Homonuclear 1H NMR and circular dichroism study of the HIV-1 Tat Eli variant. Retrovirology (2008) 0.88
Full-length HIV-1 Tat protein necessary for a vaccine. Vaccine (2004) 0.87
A sulfurtransferase is essential for activity of formate dehydrogenases in Escherichia coli. J Biol Chem (2011) 0.86
Specific binding of dehydroepiandrosterone to the N terminus of the microtubule-associated protein MAP2. J Biol Chem (2003) 0.86
Improvement of bacterial two-hybrid vectors for detection of fusion proteins and transfer to pBAD-tandem affinity purification, calmodulin binding peptide, or 6-histidine tag vectors. Proteomics (2008) 0.86
Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties. Vaccine (2007) 0.85
HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells. J Biol Chem (2009) 0.85
Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP. Biochemistry (2007) 0.84
Identification of a highly conserved surface on Tat variants. J Biol Chem (2013) 0.80
Disrupting the Acyl Carrier Protein/SpoT interaction in vivo: identification of ACP residues involved in the interaction and consequence on growth. PLoS One (2012) 0.80
A monoclonal antibody directed against a conformational epitope of the HIV-1 trans-activator (Tat) protein neutralizes cross-clade. J Biol Chem (2012) 0.80
Supramolecular organization in prokaryotic respiratory systems. Adv Microb Physiol (2012) 0.78
Posttranslational maturation of the invasion acyl carrier protein of Salmonella enterica serovar Typhimurium requires an essential phosphopantetheinyl transferase of the fatty acid biosynthesis pathway. J Bacteriol (2013) 0.78
Conformational selection underlies recognition of a molybdoenzyme by its dedicated chaperone. PLoS One (2012) 0.78
Tagging of Escherichia coli proteins with new cassettes allowing in vivo systematic fluorescent and luminescent detection, and purification from physiological expression levels. Proteomics (2009) 0.78
Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin. Biochemistry (2006) 0.78
Sexual and relationship intimacy among women with provoked vestibulodynia and their partners: associations with sexual satisfaction, sexual function, and pain self-efficacy. J Sex Med (2013) 0.76
Novel subtype C human immunodeficiency virus type 1 envelopes cloned directly from plasma: coreceptor usage and neutralization phenotypes. J Gen Virol (2010) 0.75
A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor. Bioorg Med Chem Lett (2004) 0.75